This is the sixth in a series of the 6-Question interviews with the leaders who are challenging conventional thinking in Orthopedics. (read other interviews here)
Herb Schwartz has been a quietly disruptive force in the orthopedics industry for decades. He has been innovating in tissue engineering, biologics, sports medicine, and orthopedic implants/instruments and has accumulated 37 patents. I met Herb Schwartz shortly after he left DePuy and founded Schwartz Biomedical in 2004. He later successfully sold his BioDuct meniscus repair technology to Stryker. Today, his new technology company, BioPoly, is quickly gaining traction.
I sat down with Herb to ask him a few questions.
1. Before we get into BioPoly, tell me how you ventured from your doctoral work to GE Aircraft and arrived at orthopedic innovation.
I began my career at GE Aircraft Engines which gave me a strong technical, manufacturing, and business basis because of the successful business practices of GE. From LEAN manufacturing to Six Sigma to advanced materials, GE’s leadership training provided me with the necessary tools to be successful in nearly any industry, including orthopaedics. With GE’s support, I was able to...
